VTN and neuroblastoma: has noted increased VTN expression in neuroblastoma stromal tissues, associated with poorer event‐free survival (EFS).[38] Additionally, serum protein markers identified in clinical and animal model studies suggest the potential of VTN as an early biomarker for CRC.[26] Yin et al.